Clinically relevant variants identified in thoracic aortic aneurysm patients by research exome sequencing
- 7 February 2016
- journal article
- case report
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 170 (5) , 1288-1294
Abstract
Thoracic aortic aneurysm (TAA) is a genetically heterogeneous disease involving subclinical and progressive dilation of the thoracic aorta, which can lead to life‐threatening complications such as dissection or rupture. Genetic testing is important for risk stratification and identification of at risk family members, and clinically available genetic testing panels have been expanding rapidly. However, when past testing results are normal, there is little evidence to guide decision‐making about the indications and timing to pursue additional clinical genetic testing. Results from research based genetic testing can help inform this process. Here we present 10 TAA patients who have a family history of disease and who enrolled in research‐based exome testing. Nine of these ten patients had previous clinical genetic testing that did not identify the cause of disease. We sought to determine the number of rare variants in 23 known TAA associated genes identified by research‐based exome testing. In total, we found 10 rare variants in six patients. Likely pathogenic variants included a TGFB2 variant in one patient and a SMAD3 variant in another. These variants have been reported previously in individuals with similar phenotypes. Variants of uncertain significance of particular interest included novel variants in MYLK and MFAP5, which were identified in a third patient. In total, clinically reportable rare variants were found in 6/10 (60%) patients, with at least 2/10 (20%) patients having likely pathogenic variants identified. These data indicate that consideration of re‐testing is important in TAA patients with previous negative or inconclusive results.Keywords
Funding Information
- American Heart Association innovative research (14IRG18830027)
- Burroughs Wellcome Fund Clinical Scientist (#1008496)
This publication has 21 references indexed in Scilit:
- Clinical Stratification of Pediatric Patients with Idiopathic Thoracic Aortic AneurysmThe Journal of Pediatrics, 2015
- Mutations in a TGF-β Ligand, TGFB3, Cause Syndromic Aortic Aneurysms and DissectionsJACC, 2015
- Familial thoracic aortic aneurysmsCurrent Opinion in Cardiology, 2014
- The spectrum of FBN1, TGFβR1, TGFβR2 and ACTA2 variants in 594 individuals with suspected Marfan Syndrome, Loeys–Dietz Syndrome or Thoracic Aortic Aneurysms and Dissections (TAAD)Molecular Genetics and Metabolism, 2014
- Novel MYH11 and ACTA2 mutations reveal a role for enhanced TGFβ signaling in FTAADInternational Journal of Cardiology, 2013
- TGFB2 mutations cause familial thoracic aortic aneurysms and dissections associated with mild systemic features of Marfan syndromeNature Genetics, 2012
- Genetics of Thoracic Aortic AneurysmsCurrent Atherosclerosis Reports, 2012
- Phenotypic spectrum of the SMAD3-related aneurysms–osteoarthritis syndromeJournal of Medical Genetics, 2011
- Genetic Basis of Thoracic Aortic Aneurysms and Dissections: Focus on Smooth Muscle Cell Contractile DysfunctionAnnual Review of Genomics and Human Genetics, 2008
- Medical Sequencing of Candidate Genes for Nonsyndromic Cleft Lip and PalatePLOS Genetics, 2005